https://www.marketscreener.com/quote/stock/ACLARIS-THERAPEUTICS-INC-26123625/news/Aclaris-Therapeutics-Inc-Announces-Top-Line-Results-from-12-Week-Phase-2b-Trial-of-Oral-Zunsemetin-45321837/?utm_source=telegram&utm_medium=social&utm_campaign=share